2023 Digital Healthcare Industry Conference Opens Registration: Uniting Government, Industry, Academia, Research, Medical Institutions, and Investors to Explore New Opportunities in Digital Health

With the vigorous development of digital technology, the digital economy has become an important driving force for global and China's economic development. As an essential component of the digital economy, digital trade has become increasingly important in international economic and trade cooperation, receiving attention and focus from governments and industries around the world.

Against this backdrop, the "Second Global Digital Trade Expo" (hereinafter referred to as the "Digital Trade Expo") will be held in Hangzhou to promote the in-depth development of digital trade. It is reported that the Digital Trade Expo is jointly organized by the Zhejiang Provincial People's Government and the Ministry of Commerce, and co-organized by the Hangzhou Municipal People's Government, the Zhejiang Provincial Department of Commerce, and the Foreign Trade Development Affairs Bureau of the Ministry of Commerce. As the only national, international, and professional exhibition in China with the theme of digital trade, it serves as an important window for comprehensively showcasing new technologies, products, and ecosystems in global digital trade. It is also a communication platform for jointly discussing new standards, topics, and trends in international digital trade, as well as an open platform for jointly building and sharing new markets, opportunities, and developments in economic and trade cooperation in the new era.

As one of the important forums and events of the Digital Trade Fair,"2023 Digital Healthcare Industry Conference" is scheduled to be held on November 23rd-24th.This conference was hosted by the Zhejiang Provincial People's Government and organized by government functional departments such as the Hangzhou Municipal People's Government, Zhejiang Provincial Department of Commerce, Zhejiang Provincial Health Commission, Zhejiang Provincial Department of Economy and Information Technology, Zhejiang Provincial Department of Science and Technology, Zhejiang Provincial Medical Security Bureau, and Zhejiang Provincial Drug Administration. The Archview District People's Government of Hangzhou, AstraZeneca, and Takeda Pharmaceuticals were the executive units.This Digital Healthcare Industry Conference is also the only conference jointly organized by the government and enterprises during this Digital Trade Fair, aiming to explore new opportunities for digital healthcare development by aggregating the strengths of government, industry, academia, research, and investment.

The executive organizer of this conference, Gongshu District Government, has been vigorously developing and promoting the life and health industry. It has successively established a number of high-quality projects such as the East China Institute of Synthetic Biology Industry Technology, Yanglin Bio, etc. Meanwhile, it actively leverages leading enterprises like AstraZeneca Investment China’s Eastern Headquarters, Daegu Life Health Industry Cluster from South Korea, and BD Medical to strengthen platform support for “One Valley and Four Parks,” including Banshan Life Health Valley, East China Medicine Life Science Industrial Park, AstraZeneca International Life Science Innovation Park, Kangqiao Health Industrial Park, and Fengqi Valley Life Health Industrial Park. In the future, Gongshu District will also actively play the role of industrial funds in driving development, accelerate the introduction of high-quality upstream and downstream enterprises in the industrial chain, and focus on developing fields such as biopharmaceutical R&D, digital healthcare, pharmaceutical distribution, medical aesthetics and health, and smart health services. The district aims to introduce and gather a group of enterprises and projects that build and strengthen the industrial chain, construct a comprehensive life and health industry ecosystem, and create an internationally leading life and health industry cluster.

(Click the image to register for the conference)

Throughout the evolution of the global technology industry ecosystem, only when all parties in the industry collaborate and coexist can the entire sector achieve higher-dimensional development. This principle also applies to the digital healthcare field.

In response to this, the "2023 Digital Healthcare Industry Conference" built a cross-disciplinary exchange and cooperation platform around the needs of all parties in the industry, truly enabling participants to gain valuable insights.

The "2023 Digital Healthcare Industry Conference" serves as a platform for all parties in the digital healthcare industry to exchange ideas, cooperate, and voice opinions, as well as a special invitation to attract more participants to join the ecosystem. To ensure the quality of topic discussions to the greatest extent,The conference features 1 main forum, 2 sub-forums, and 1 closed-door meeting, with a rich variety of meeting formats.

This conference covered guests from multiple circles, including government, industry, academia, research, medicine, and investment., featuring numerous industry experts. Not only can it provide insights into the cutting-edge trends of digital healthcare, but it also offers attendees an opportunity to engage in face-to-face exchanges with top experts in the field. The conference will invite leading figures from various industries to discuss hot topics such as the integration of the digital healthcare ecosystem and industrial symbiosis, attracting over a thousand participants.Top industry experts and leaders, high-growth companies, technical specialists, and professional investors attended.

It is worth mentioning that,The 2023 Digital Healthcare Industry Conference will specially establishDigital Healthcare Professional Committee and the Alliance for Promoting Common ProsperityThe Digital Healthcare Professional Committee has four main responsibilities: First, to explore industry innovation and ecosystem construction; second, to promote government-business exchanges and cooperation; third, to facilitate the sustainable development of the Digital Trade Fair (DTF); and fourth, to enhance corporate social responsibility. Additionally, member companies of the Digital Healthcare Professional Committee will announce their annual public welfare activities during the DTF and actively participate in public welfare events organized by the DTF and various sectors of society, contributing to the promotion of common prosperity through digital healthcare.

In order to better establish a "bridge" for government-enterprise communication, the main forum also specially set up a closed-door meeting between the government and enterprises to bring Hangzhou closer to digital medical and health innovation companies, deepen government-enterprise cooperation, and promote the integration of high-quality resources.

At this conference, international pharmaceutical leaders AstraZeneca and Takeda China, leveraging their own strengths and industry influence, hosted the AstraZeneca China Digital Healthcare Industry Development Forum and the Takeda China Digital Healthcare Innovation Conference, jointly discussing industry development trends and showcasing the latest achievements.

AstraZeneca Investment China Digital Healthcare Industry Development Forum Includes Two Sub-Forums.

The First Digitalization of Medical Industry Forum, will invite relevant government leaders, McKinsey, Eight Roads, BioMap, ZhiZhong Medical, Alibaba Cloud Intelligent Lingyang, 4Paradigm, Huiyi Online, Zeqiao Media, MaiLuo Insights, Tencent Health and other ecosystem partners to discuss topics such as the development, trends, and advanced technology practices in the digital health industry.

On site,Hangzhou International Life Science Innovation Park (iCampus) will also welcome a new group of digital healthcare innovation companies to settle in, jointly promoting the innovation of digital healthcare in Hangzhou.The International Life Science Innovation Park (iCampus) is one of the three innovative "driving forces" created by AstraZeneca in response to the government's call for "innovation-driven development." Currently, 24 innovative companies have settled into Hangzhou iCampus, making it a strong promoter of digital healthcare innovation in Hangzhou.

The Second Digital Healthcare Innovation and Transformation ForumFocusing on "Achievement Promotion, Targeted Incubation, and Industrial Integration," relevant leaders from the Zhejiang Provincial Government departments will be invited to interpret policies on the transformation of scientific research achievements. Attendees will also have the opportunity to hear about innovative practices in integrated diagnostic and treatment solutions in the fields of respiratory, metabolic, and oncological diseases.

In the second half, 10 digital healthcare innovation projects from renowned clinical experts will be presented in an exciting roadshow.Top-tier investment institutions such as CICC Capital, Qiming Venture Partners, Kaitai Capital, and Yisheng Capital will interact with clinical experts to explore the commercial pathways of the projects.

At the same time, during the current Digital Trade Fair,AstraZeneca to Showcase with Ecosystem Partners at the 3C Frontier Trends Pavilion, showcasing its integrated diagnostic and therapeutic solutions in fields such as metabolism, respiratory, oncology, and primary care. Ecosystem partners will present nearly 20 digital healthcare innovation products, covering all stages of disease screening, diagnosis, treatment, and management.

During the Digital Healthcare Industry Conference, Takeda China, a well-known multinational pharmaceutical company, will host the "Digital Momentum, Innovation for the Future" Digital Healthcare Innovation Conference. The event plans to invite relevant government leaders, experts from renowned tertiary hospitals, experts from prestigious universities in China, key industry partners, and guests from various sectors. Focusing on the cutting-edge innovations in digital healthcare, the conference will gather professional insights covering the entire industrial chain from "government, industry, academia, research, and investment," discussing the present and future of digital healthcare innovation.

In addition, Takeda China will further upgrade the TakedaSpark partner lineup at the conference site and sign strategic cooperation agreements with diversified partners. Based on years of exploration experience, Takeda China will also join hands with its partners to release a report on digital healthcare practices and insights, providing the industry with a valuable reference for innovative digital healthcare practices.

At the same time, Takeda China will set up a digital healthcare experience center outside the venue to offer all guests an in-depth interactive experience, allowing them to personally experience the commercial application scenarios of digital medical technology.

The development of the industry requires long-term synergy among all ecological parties.In this regard, Hangzhou City has actively laid out its strategies, attracting numerous multinational pharmaceutical companies to establish operations and develop together.

As one of the earliest multinational pharmaceutical companies in China to focus on digital healthcare, AstraZeneca has been actively contributing to the development of China's digital healthcare industry. Through initiatives such as the China Smart Health Innovation Center (CCiC), the International Life Science Innovation Park (iCampus), and the AstraZeneca Zhongjin Healthcare Industry Fund, AstraZeneca has been enhancing the industry ecosystem. The company’s deep involvement in the Digital Trade Fair and its collaboration with governments at all levels to organize the Digital Healthcare Industry Conference is yet another testament to AstraZeneca’s continued commitment to advancing the digital healthcare industry.

At the same time, this conference covers numerous upstream and downstream enterprises in the digital healthcare industry as well as relevant government departments, promoting the introduction and aggregation of enterprises and projects that strengthen industrial chains to Hangzhou. It aims to attract more digital healthcare companies to learn about Zhejiang, become familiar with Hangzhou, build a comprehensive life sciences industrial ecosystem, and create a platform for connecting and advancing the digital healthcare industry.

It is not difficult to find that,Taking international pharmaceutical leading enterprises as a blueprint, Hangzhou will attract more global companies to participate in the construction of the local digital healthcare ecosystem, lead the development of the digital healthcare industry, and help the Healthy China initiative to continuously take root.

"Sky's the limit, and the sea allows fish to leap as high as they want." In the booming development of the digital healthcare industry, we welcome you all to attend the "2023 Digital Healthcare Industry Conference" to witness and experience firsthand the rise of the industry.

November 23rd-24th, Hangzhou, see you there!

Scan the QR code to register for the conference

Registration will close at 21:00 on November 15.